21
Participants
Start Date
January 31, 2006
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Recombinant Human Growth Hormone
Dosage increased in steps for first four weeks. Self injection qd x 12 weeks
Placebo for Recombinant Human Growth Hormone
Administered as Arm 1, rHGH active Injection qd x 12 weeks Dosage increase over four weeks
Massachusettes General Hospital, Boston
Collaborators (1)
Genentech, Inc.
INDUSTRY
Massachusetts General Hospital
OTHER